Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
vonsetamig (REGN5459) / Regeneron
NCT04083534: First In Human (FIH) Study of REGN5459 in Adult Patients With Relapsed or Refractory Multiple Myeloma (MM)	Active, not recruiting	1/2	43	US	REGN5459	Regeneron Pharmaceuticals	Relapsed Multiple Myeloma, Refractory Multiple Myeloma	08/25	11/25
NCT05092347: Study for Desensitization of Chronic Kidney Disease in Adult Patients in Need of a Kidney Transplant Who Are Highly Sensitized to Human Leukocyte Antigen	Recruiting	1/2	60	US	REGN5459, BCMAxCD3, REGN5458, linvoseltamab	Regeneron Pharmaceuticals	Chronic Kidney Disease (CKD)	10/25	10/25
NCT05106387: An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive A Kidney Transplant	Recruiting	N/A	12	US	Noninterventional	Regeneron Pharmaceuticals	Chronic Kidney Disease (CKD)	05/26	05/26